2 ARMS/GROUPS: CONTINOUS OUTCOMES (e.g. BMD, BP)

UI Author Year Outcome Unit Exposure/Intervention Mean Follow-up, mo No. Analyzed Baseline Baseline SD * Final or Delta ** Final or Delta CI/SE/SD * Net difference Net difference CI/SE/SD * P between
9022561 Whelton, 1997 SBP mm Hg Ca supplement 18 mo 221 126.0 7.7 nd nd ~−0.5 (figure) ~0.75 NS
Placebo 224 125.4 8.8 nd nd
9022561 Whelton, 1997 DBP mm Hg Ca supplement 18 mo 221 84.1 2.9 nd nd ~+0.3 (figure) ~0.5 NS
Placebo 224 83.9 2.8 nd nd

Baseline=baseline value; Final=final value; Delta=change value from baseline, which is Final-Baseline value; Net difference=differences in deltas

*

Enter outcome metric reported in the unadjusted or adjusted result section

**

Delta value is preferred than the Final value. Please report the direction for the change by using “+” or “−“ sign: e.g. +2.8 or −2.8

From: Appendix C, Evidence Tables: R-Z

Cover of Vitamin D and Calcium
Vitamin D and Calcium: A Systematic Review of Health Outcomes.
Evidence Reports/Technology Assessments, No. 183.
Chung M, Balk EM, Brendel M, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.